• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于血液的诊断开发的计算机模拟建模,稳健检测ZNF154的DNA高甲基化作为泛癌基因座

Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.

作者信息

Margolin Gennady, Petrykowska Hanna M, Jameel Nader, Bell Daphne W, Young Alice C, Elnitski Laura

机构信息

Translational and Functional Genomics Branch, National Human Genome Research Institute, Rockville, Maryland.

Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, Bethesda, Maryland.

出版信息

J Mol Diagn. 2016 Mar;18(2):283-98. doi: 10.1016/j.jmoldx.2015.11.004. Epub 2016 Feb 5.

DOI:10.1016/j.jmoldx.2015.11.004
PMID:26857064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4816708/
Abstract

Sites that display recurrent, aberrant DNA methylation in cancer represent potential biomarkers for screening and diagnostics. Previously, we identified hypermethylation at the ZNF154 CpG island in 15 solid epithelial tumor types from 13 different organs. In this study, we measure the magnitude and pattern of differential methylation of this region across colon, lung, breast, stomach, and endometrial tumor samples using next-generation bisulfite amplicon sequencing. We found that all tumor types and subtypes are hypermethylated at this locus compared with normal tissue. To evaluate this site as a possible pan-cancer marker, we compare the ability of several sequence analysis methods to distinguish the five tumor types (184 tumor samples) from normal tissue samples (n = 34). The classification performance for the strongest method, measured by the area under (the receiver operating characteristic) curve (AUC), is 0.96, close to a perfect value of 1. Furthermore, in a computational simulation of circulating tumor DNA, we were able to detect limited amounts of tumor DNA diluted with normal DNA: 1% tumor DNA in 99% normal DNA yields AUCs of up to 0.79. Our findings suggest that hypermethylation of the ZNF154 CpG island is a relevant biomarker for identifying solid tumor DNA and may have utility as a generalizable biomarker for circulating tumor DNA.

摘要

在癌症中显示出反复出现的异常DNA甲基化的位点代表了用于筛查和诊断的潜在生物标志物。此前,我们在来自13个不同器官的15种实体上皮肿瘤类型中鉴定出ZNF154 CpG岛的高甲基化。在本研究中,我们使用下一代亚硫酸氢盐扩增子测序来测量该区域在结肠癌、肺癌、乳腺癌、胃癌和子宫内膜癌肿瘤样本中的甲基化差异程度和模式。我们发现,与正常组织相比,所有肿瘤类型和亚型在该位点均发生高甲基化。为了评估该位点作为一种可能的泛癌标志物的可能性,我们比较了几种序列分析方法区分五种肿瘤类型(184个肿瘤样本)与正常组织样本(n = 34)的能力。通过(受试者操作特征)曲线下面积(AUC)衡量的最强方法的分类性能为0.96,接近完美值1。此外,在循环肿瘤DNA的计算模拟中,我们能够检测到用正常DNA稀释的有限量肿瘤DNA:在99%正常DNA中的1%肿瘤DNA产生的AUC高达0.79。我们的研究结果表明,ZNF154 CpG岛的高甲基化是鉴定实体肿瘤DNA的相关生物标志物,并且可能作为循环肿瘤DNA的通用生物标志物具有实用价值。

相似文献

1
Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.通过基于血液的诊断开发的计算机模拟建模,稳健检测ZNF154的DNA高甲基化作为泛癌基因座
J Mol Diagn. 2016 Mar;18(2):283-98. doi: 10.1016/j.jmoldx.2015.11.004. Epub 2016 Feb 5.
2
Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines.在广泛的人类实体上皮肿瘤和癌细胞系中,ZNF154、CASP8 和 VHL 启动子中的 DNA 甲基化的反复模式。
Epigenetics. 2013 Dec;8(12):1355-72. doi: 10.4161/epi.26701. Epub 2013 Oct 22.
3
Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients.评估患者血浆中的 ZNF154 甲基化作为结直肠癌、肝癌、卵巢癌和胰腺癌患者液体活检中的多癌种标志物。
Sci Rep. 2021 Jan 8;11(1):221. doi: 10.1038/s41598-020-80345-7.
4
Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.通过多重 MethyLight 分析检测血清 DNA 中 HOXA9 和 HIC1 的异常甲基化,用于上皮性卵巢癌的早期检测。
Int J Cancer. 2020 Sep 15;147(6):1740-1752. doi: 10.1002/ijc.32984. Epub 2020 Mar 31.
5
Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers.利用基因座特异性表观遗传异质性提高基于血液的 DNA 甲基化生物标志物的性能。
Clin Epigenetics. 2020 Oct 20;12(1):154. doi: 10.1186/s13148-020-00939-w.
6
Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.使用亚硫酸氢盐新一代测序技术对血浆游离DNA进行甲基化分析以实现乳腺癌早期检测
Tumour Biol. 2016 Oct;37(10):13111-13119. doi: 10.1007/s13277-016-5190-z. Epub 2016 Jul 23.
7
Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.鉴定人肝癌中内含子保留产生的非编码 KLF4 转录本及其下调表达。
Int J Oncol. 2015 Oct;47(4):1554-62. doi: 10.3892/ijo.2015.3104. Epub 2015 Jul 24.
8
ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.ZNF154 是一种很有前途的诊断生物标志物,可预测前列腺癌的生化复发。
Gene. 2018 Oct 30;675:136-143. doi: 10.1016/j.gene.2018.06.104. Epub 2018 Jul 4.
9
Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.全基因组DNA甲基化测序揭示miR-663a是CIMP高的子宫内膜癌中一种新的表观突变候选基因。
Int J Oncol. 2017 Jun;50(6):1934-1946. doi: 10.3892/ijo.2017.3966. Epub 2017 Apr 19.
10
Hypermethylation of CpG islands in primary and metastatic human prostate cancer.原发性和转移性人类前列腺癌中CpG岛的高甲基化
Cancer Res. 2004 Mar 15;64(6):1975-86. doi: 10.1158/0008-5472.can-03-3972.

引用本文的文献

1
Advances and challenges in the use of liquid biopsy in gynaecological oncology.液体活检在妇科肿瘤学中的应用进展与挑战
Heliyon. 2024 Oct 15;10(20):e39148. doi: 10.1016/j.heliyon.2024.e39148. eCollection 2024 Oct 30.
2
Evaluation of a multimodal ctDNA-based assay for detection of aggressive cancers lacking standard screening tests.评估一种基于多模态循环肿瘤DNA的检测方法,用于检测缺乏标准筛查检测的侵袭性癌症。
Future Oncol. 2025 Jan;21(1):105-115. doi: 10.1080/14796694.2024.2413266. Epub 2024 Oct 21.
3
Universal penalized regression (Elastic-net) model with differentially methylated promoters for oral cancer prediction.基于差异甲基化启动子的通用惩罚回归(Elastic-net)模型用于口腔癌预测。
Eur J Med Res. 2024 Sep 11;29(1):458. doi: 10.1186/s40001-024-02047-4.
4
Epigenetic characterization of housekeeping core promoters and their importance in tumor suppression.管家核心启动子的表观遗传学特征及其在肿瘤抑制中的重要性。
Nucleic Acids Res. 2024 Feb 9;52(3):1107-1119. doi: 10.1093/nar/gkad1164.
5
Evaluating Stacked Methylation Markers for Blood-Based Multicancer Detection.评估用于基于血液的多癌检测的叠加甲基化标志物
Cancers (Basel). 2023 Oct 1;15(19):4826. doi: 10.3390/cancers15194826.
6
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests.改变癌症筛查模式:基于血液的多癌种早期检测测试的崛起潜力。
Cells. 2023 Mar 18;12(6):935. doi: 10.3390/cells12060935.
7
Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis.综合分析揭示了酒精相关癌症的常见DNA甲基化模式:一项泛癌分析。
Front Genet. 2023 Feb 13;14:1032683. doi: 10.3389/fgene.2023.1032683. eCollection 2023.
8
Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells.靶向 ZNF154 启动子去甲基化可上调 ZNF154 的表达,并抑制食管鳞癌细胞的增殖和迁移。
Oncogene. 2022 Sep;41(40):4537-4546. doi: 10.1038/s41388-022-02366-y. Epub 2022 Sep 5.
9
Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis.肺癌脑转移过程中发育途径会发生表观遗传重编程。
Cancer Res. 2022 Aug 3;82(15):2692-2703. doi: 10.1158/0008-5472.CAN-21-4160.
10
Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer.锌指蛋白154(ZNF154)低表达与胃癌预后不良相关。
Cancer Manag Res. 2022 Feb 17;14:659-672. doi: 10.2147/CMAR.S340053. eCollection 2022.

本文引用的文献

1
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.循环肿瘤细胞、外泌体和循环肿瘤核酸具有临床应用价值吗?分子病理学协会的一份报告。
J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001.
2
A coherent approach for analysis of the Illumina HumanMethylation450 BeadChip improves data quality and performance in epigenome-wide association studies.一种用于分析Illumina HumanMethylation450 芯片的连贯方法可提高全表观基因组关联研究中的数据质量和性能。
Genome Biol. 2015 Feb 15;16(1):37. doi: 10.1186/s13059-015-0600-x.
3
Quantification of epigenetic biomarkers: an evaluation of established and emerging methods for DNA methylation analysis.表观遗传生物标志物的定量分析:对DNA甲基化分析的既定方法和新兴方法的评估
BMC Genomics. 2014 Dec 23;15(1):1174. doi: 10.1186/1471-2164-15-1174.
4
DNA methylation biomarkers: cancer and beyond.DNA甲基化生物标志物:癌症及其他领域
Genes (Basel). 2014 Sep 16;5(3):821-64. doi: 10.3390/genes5030821.
5
DNA methylation as an early diagnostic marker of cancer (Review).DNA甲基化作为癌症的早期诊断标志物(综述)。
Biomed Rep. 2014 May;2(3):326-330. doi: 10.3892/br.2014.237. Epub 2014 Feb 14.
6
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.新型甲基化生物标志物及稳健检测方法可检测转移性乳腺癌循环肿瘤 DNA
Cancer Res. 2014 Apr 15;74(8):2160-70. doi: 10.1158/0008-5472.CAN-13-3392.
7
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.一种用于定量循环肿瘤DNA的超灵敏方法,具有广泛的患者覆盖范围。
Nat Med. 2014 May;20(5):548-54. doi: 10.1038/nm.3519. Epub 2014 Apr 6.
8
Detection of circulating tumor DNA in early- and late-stage human malignancies.早期和晚期人类恶性肿瘤中循环肿瘤DNA的检测
Sci Transl Med. 2014 Feb 19;6(224):224ra24. doi: 10.1126/scitranslmed.3007094.
9
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
10
Characterizing DNA methylation alterations from The Cancer Genome Atlas.从癌症基因组图谱中描述 DNA 甲基化改变。
J Clin Invest. 2014 Jan;124(1):17-23. doi: 10.1172/JCI69740. Epub 2014 Jan 2.